J.P. Morgan analyst Anupam Rama maintained a Buy rating on Maze Therapeutics, Inc. yesterday and set a price target of $53.00. The company’s shares......

Maze Therapeutics, Inc. ( ($MAZE) ) just unveiled an announcement. On May 18, 2026, Maze Therapeutics, Inc. announced that Senior Vice President of......

LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Maze Therapeutics, Inc. today and set a price target of $57.00. Katkhuda covers th......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Shoulder Innovations, Inc. (SI), Maze Therapeutics, ......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Maze Therapeutics, Inc. (MAZE) and Anixa Biosciences......